Press Releases

 
Press Releases
  Date Title View
Feb 3, 2016
REDWOOD CITY, Calif., Feb. 3, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 10 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2015 financial results. The call and webcast will follow the release of the fourth quarter and ...
PDF
Jan 11, 2016
REDWOOD CITY, Calif., Jan. 11, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced plans to launch its first liquid biopsy test, Oncotype SEQ™, in mid-2016. The test is a blood-based mutation panel that uses next-generation sequencing to identify select actionable genomic alterations for the treatment of patients with lat...
PDF
Jan 8, 2016
REDWOOD CITY, Calif., Jan. 8, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced preliminary revenue for the year ended December 31, 2015, is expected to be between $285 and $286 million, compared with $275.7 million in 2014, representing an increase of approximately 4 percent, slightly below the Company's 2015 guidance. ...
PDF
Jan 4, 2016
REDWOOD CITY, Calif., Jan. 4, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Chairman, Chief Executive Officer and President, will present at the 34th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 11, 2016 at 3:30 p.m. Pacific Time. To...
PDF
Dec 15, 2015
REDWOOD CITY, Calif., Dec. 15, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple Oncotype DX® breast cancer test studies at the 38th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) reconfirming that Oncotype DX accurately predicts clinical outcomes - including risk of recurrence and breast can...
PDF
Dec 9, 2015
REDWOOD CITY, Calif., Dec. 9, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from eight Oncotype DX® breast cancer test studies at the 38th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  Presentations in invasive breast cancer, ductal carcinoma in situ (DCIS) and next-gen...
PDF
Nov 18, 2015
REDWOOD CITY, Calif., Nov. 18, 2015 /PRNewswire/ -- On Tuesday, November 17, 2015, the Centers for Medicare and Medicaid Services (CMS), which administers the Medicare program, issued its final Clinical Laboratory Fee Schedule (CLFS) for 2016, which will allow the Medicare Administrative Contractor (MAC) to continue to set payment for the Oncotype ...
PDF
Nov 16, 2015
REDWOOD CITY, Calif., Nov. 16, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from eight Oncotype DX® breast cancer test studies at the 38th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), taking place December 8-12, 2015 at the Henry B. Gonzalez Convention Center.  Present...
PDF
Nov 3, 2015
REDWOOD CITY, Calif., Nov. 3, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2015. Revenue was $73.6 million in the third quarter of 2015 compared with $69.1 million for the third quarter of 2014, an increase of 6 percent. On a constant curre...
PDF
Nov 3, 2015
REDWOOD CITY, Calif., Nov. 3, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in November: Brad Cole, chief operating officer and chief financial officer, will present at the 24th Annual Credit Suisse Healthcare Conference in Phoenix, A...
PDF
1
...
NextLast